Larger beagle image


An accessible and affordable blood test to aid in early detection of cancer in dogs.


Earlier cancer detection improves outcomes.

It also improves the quality of life of the dog and its owner.

The Nu.Q® Vet Cancer Test is an affordable and accessible screening test to aid early detection. It is a simple, easy to use blood test for healthy, older dogs (7 years and older), as well as younger dogs (4 year and older) in breeds with an increased risk of developing cancer.

The Nu.Q® Vet Cancer Test is a science-backed tool that you can easily integrate into your preventive care program. It provides you with data-driven insights for a proactive care approach, to support your clinical decision making and enable you to guide pet owners with increased confidence.

Heather_Wilson_Robles & Otis
Introducing Nu.Q® Vet Cancer Test

How does the Nu.Q® Vet Cancer Test work?

What does the Nu.Q® Vet Cancer Test measure?

When cancer is present, nucleosomes – originating from the cancer cells – enter the bloodstream. They can be captured using antibodies tailored specifically to detect nucleosomes.

The Nu.Q® Vet Cancer Test quantifies these circulating nucleosome levels in the blood. The test needs just 0.5ml of plasma, obtainable from a 2-5ml blood draw after centrifugation.

By measuring and analyzing nucleosomes, our Nu.Q® Vet Cancer Test can help identify patients who may have a cancer. This must then be confirmed by follow-up procedures – for example, a biopsy or scan. 

Image 25-01-2024 at 11.10

What types of cancer has the Nu.Q® Vet Cancer Test been able to detect?

The Nu.Q® Vet Cancer Test can detect cancers such as lymphoma and hemangiosarcoma, even at early stages. Preliminary data suggests that this screening test can also detect some instances of Mast Cell tumours, malignant melanomas and Histiocytic Sarcoma. The current Nu.Q® Vet Cancer Test more reliably detects systemic cancers rather than soft tissue or localized cancers.

Image 25-01-2024 at 11.14 (2)

How to take a sample and interpret the results

Visit our Nu.Q® Vet Cancer Test product information page for a step-by-step guide on how to take a sample from your patient and interpret the results.

Veterinarian Stroking Dog Close Up
Clinical Evidence

The research behind the results

In a peer-reviewed and published case series, the Nu.Q® Vet Cancer Test was shown to detect 76% of systemic cancers.

  • 77% lymphoma
  • 82% hemangiosarcoma
  • 54% histiocytic sarcoma

Our test was able to identify approximately 50% of all cancers researched at 97% specificity.

Lymphoma is the most common form of canine cancer and together with hemangiosarcoma make up approximately one-third of all cancers.


Study details:

  • A total of 662 dogs were included in the study (134 healthy and 528 with cancer).
  • A variety of breeds, weights and cancer stages were represented
  • 7 cancers were evaluated: Lymphoma, Malignant melanoma, Hemangiosarcoma, Mast cell tumors, Osteosarcoma, Histiocytic sarcoma and Soft tissue sarcoma.
0 %

of systematic cancers detected

0 %

of all cancers researched

Introduce Nu.Q® Vet into your clinic

Our test is currently available in the United States, Europe, and Asia through reference laboratories which include IDEXX and Heska/Antech. It is also available as an in-house test exclusively via Heska/Antech.


You can find details of your local distributor below.

Get in touch with our vet team

Our expert team will be on hand to offer guidance and support and to fulfil your needs.

"*" indicates required fields

Enter your contact details*